Cite
HARVARD Citation
Mori, T. et al. (2019). Multi‐institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG‐G1201). Journal of obstetrics and gynaecology research. 45 (3), pp. 671-678. [Online].